Rybelsus Oral Tablets
  1. Home
  2. Rybelsus
  3. Rybelsus Oral Tablets

Rybelsus Oral Tablets

Rybelsus Oral Tablets are prescription GLP-1 receptor agonist tablets indicated for improving glycemic control in adults with type 2 diabetes when used alongside diet and exercise. They provide convenient once-daily oral administration without the need for injections. The tablet formulation offers an effective option for long-term diabetes management.

BUY NOW

Category

Rybelsus Oral Tablets contain semaglutide, a GLP-1 receptor agonist that helps improve blood glucose control by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The once-daily oral formulation provides a non-injectable alternative for eligible patients requiring GLP-1 therapy while supporting consistent glycemic management. Manufactured under stringent pharmaceutical quality standards, the tablets are supplied in blister packs for convenient dosing and storage. Rybelsus should be taken only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Rybelsus Oral Tablets
Active Ingredient Semaglutide
Dosage Form Oral Tablets
Available Strengths 3 mg, 7 mg, 14 mg
Route of Administration Oral
Storage Store below 30°C in a dry place

Product Also Known As

Rybelsus Oral Tablets, Rybelsus Tablets, Semaglutide Oral Tablets, Oral Semaglutide Tablets, GLP-1 Oral Tablets, Semaglutide Diabetes Tablets, Once-Daily Semaglutide Tablets